KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Prepaid Assets (2023 - 2025)

Biocryst Pharmaceuticals' Prepaid Assets history spans 9 years, with the latest figure at $17.2 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 24.94% year-over-year to $17.2 million; the TTM value through Dec 2025 reached $17.2 million, up 24.94%, while the annual FY2025 figure was $17.2 million, 24.94% up from the prior year.
  • Prepaid Assets reached $17.2 million in Q4 2025 per BCRX's latest filing, up from $16.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $20.0 million in Q3 2023 to a low of $12.5 million in Q2 2025.
  • Average Prepaid Assets over 3 years is $16.2 million, with a median of $16.4 million recorded in 2024.
  • Peak YoY movement for Prepaid Assets: fell 29.63% in 2024, then grew 24.94% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $19.5 million in 2023, then dropped by 29.63% to $13.8 million in 2024, then increased by 24.94% to $17.2 million in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Prepaid Assets are $17.2 million (Q4 2025), $16.5 million (Q3 2025), and $12.5 million (Q2 2025).